Shiping Cao
Overview
Explore the profile of Shiping Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nai W, Lei L, Zhang Q, Yan S, Xu J, Lin L, et al.
Nutr Metab Cardiovasc Dis
. 2024 Dec;
35(3):103787.
PMID: 39734133
Background And Aim: The relationship between the systemic inflammatory response index (SIRI) and carotid atherosclerosis has not yet been assessed in a longitudinal investigation. Our current study aimed to investigate...
2.
Ju C, Xie X, Tang S, Cao S
Front Cardiovasc Med
. 2023 Oct;
10:1277528.
PMID: 37840951
Introduction: Permanent pacemaker implantation (PPI) is a known complication in patients with aortic stenosis following transcatheter aortic valve implantation (TAVI). However, there is limited research on TAVI for pure aortic...
3.
Xiao Z, Lin Z, Xu L, Xu W, Huang H, Wang Y, et al.
Eur J Prev Cardiol
. 2023 Sep;
30(17):1924-1934.
PMID: 37708385
Aims: Remnant cholesterol (RC) reportedly mediates residual cardiovascular risk in atherosclerotic cardiovascular diseases (ASCVD). However, few studies have characterized long-term cumulative RC exposure among elderly people. The study aimed to...
4.
Zhang S, Lu C, Cao S, Li Q, Wu G, Zhao L
Biotechnol Biofuels Bioprod
. 2023 Jun;
16(1):107.
PMID: 37386510
Industrial application of icariin and baohuoside I has been hindered by the short supply to a great extent. In this work, a novel GH78 α-L-rhamnosidase AmRha catalyzed the bioconversion of...
5.
Li X, Guo S, Xu T, He X, Sun Y, Chen X, et al.
Theranostics
. 2023 May;
13(7):2259-2262.
PMID: 37153729
[This corrects the article DOI: 10.7150/thno.39553.].
6.
Liang H, Zhang Q, Gao Y, Chen G, Bai Y, Zhang Y, et al.
Eur Radiol
. 2023 May;
33(10):6771-6780.
PMID: 37133521
Objectives: Blood flow into the side branch affects the calculation of coronary angiography-derived fractional flow reserve (FFR), called Angio-FFR. Neglecting or improperly compensating for the side branch flow may decrease...
7.
Shen M, Zheng C, Chen L, Li M, Huang X, He M, et al.
Biomed Pharmacother
. 2023 Mar;
162:114569.
PMID: 37001183
Background: Right ventricular (RV) function is a major prognostic factor in patients with cardiopulmonary disease. Effective medical therapies are available for left heart failure, but they are usually less effective...
8.
Zhang X, Xie J, Cao S, Zhang H, Pei J, Bu S, et al.
Appl Microbiol Biotechnol
. 2023 Mar;
107(9):2831-2842.
PMID: 36930276
Baicalein-7-O-glucoside and baicalein-7-O-rhamnoside have been proven to possess many pharmacological activities and are potential candidate drug leads and herb supplements. However, their further development is largely limited due to low...
9.
Su J, Wu T, Cao S, Pei J, Zhao L
Bioorg Chem
. 2023 Jan;
132:106364.
PMID: 36706530
Among the flavonoids of epimedium, epimedin B, epimedin C, and icariin are considered to be representative components and their structures are quite similar. Besides sharing the same backbone, the main...
10.
Hao H, Ma S, Zheng C, Wang Q, Lin H, Chen Z, et al.
Aging (Albany NY)
. 2021 Jan;
13(2):2982-3009.
PMID: 33460402
Cardiorenal syndrome (CRS) has a high mortality, but its pathogenesis remains elusive. Fibroblast growth factor 23 (FGF23) is increased in both renal dysfunction and cardiac dysfunction, and FGF receptor 4...